References
Badagliacca R, Pezzuto B, Poscia R, Mancone M, Papa S, Marcon S, Valli G, Sardella G, Ferrante F, Iacoboni C, Parola D, Fedele F, Vizza CD (2012) Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy: the impact of late referral. J Heart Lung Transplant 31:364–372
Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, SHIFT Investigators (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376:875–885
Nuding S, Ebelt H, Hoke RS, Krummenerl A, Wienke A, Müller-Werdan U, Werdan K (2011) Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I(f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial. Clin Res Cardiol. 100:915–923
De Santis V, Vitale D, Santoro A, Magliocca A, Porto AG, Nencini C, Tritapepe L (2012) Ivabradine: potential clinical applications in critically ill patients Clin Res Cardiol (2012 Oct 14 Epub ahead of print)
Zhang R, Bobylev D, Stiefel P, Haverich A, Bara C (2012) Lasting reduction of heart transplant tachycardia with ivabradine is effective and well tolerated: results of 48-month study. Clin Res Cardiol. 101:631–636
Vitale D, De Santis V, Guarracino F, Fontana A, Pellegrini F, Tritapepe L (2010) Use of ivabradine in catecholamine-induced tachycardia after high-risk cardiac surgery. Clin Res Cardiol. 99:853–855
Correale M, Montrone D, Di Biase M, Brunetti ND (2012) Safe and well-tolerated treatment with ivabradine in systemic sclerosis affected by pulmonary hypertension. Clinic Res Cardiol. 101:593–594
Correale M, Montrone D, Ieva R, Di Biase M, Brunetti ND (2012) Ivabradine in systemic sclerosis related pulmonary arterial hypertension. Eur J Intern Med (2012 Sep 25 Epub ahead of print)
de Man FS, Handoko ML, van Ballegoij JJ, Schalij I, Bogaards SJ, Postmus PE, van der Velden J, Westerhof N, Paulus WJ, Vonk-Noordegraaf A (2012) Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension. Circ Heart Fail. 5:97–105
Akhmetzianova ÉK, Gaĭnitdinova VV, Bakirov AB, Bogoroditskaia OA, Timershina IR (2012) Effect of ivabradine on pulmonary hypertension in chronic obstructive pulmonary disease. Kardiologiia. 52:41–46
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Correale, M., Montrone, D., Ieva, R. et al. Ivabradine in pulmonary arterial hypertension: can we delay the need for parenteral prostanoid therapy?. Clin Res Cardiol 102, 391–393 (2013). https://doi.org/10.1007/s00392-013-0541-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-013-0541-x